{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:41:03Z","timestamp":1792597263616,"version":"4.5.0"},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,19]]},"DOI":"10.1093\/neuonc\/nox094","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T19:09:24Z","timestamp":1493752164000},"page":"1447-1456","source":"Crossref","is-referenced-by-count":165,"title":["BAP1 mutations in high-grade meningioma: implications for patient care"],"prefix":"10.1093","volume":"19","author":[{"given":"Ganesh M","family":"Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0001","first-page":"535","article-title":"Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas","volume":"19","year":"2017","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0002","first-page":"345","article-title":"SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas","volume":"19","year":"2017","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0003","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","year":"2013","journal-title":"Nat Genet"},{"issue":"6123","key":"key\n\t\t\t\t20171219125453_CIT0004","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","year":"2013","journal-title":"Science"},{"issue":"10","key":"key\n\t\t\t\t20171219125453_CIT0005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ng.3651","article-title":"Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas","volume":"48","year":"2016","journal-title":"Nat Genet"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0006","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0007","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"21","key":"key\n\t\t\t\t20171219125453_CIT0008","doi-asserted-by":"crossref","first-page":"10596","DOI":"10.18632\/oncotarget.2517","article-title":"Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5","volume":"5","year":"2014","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20171219125453_CIT0009","doi-asserted-by":"crossref","first-page":"14433","DOI":"10.1038\/ncomms14433","article-title":"Integrated genomic analyses of de novo pathways underlying atypical meningiomas","volume":"8","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-3639.2002.tb00433.x","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","year":"2002","journal-title":"Brain Pathol"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0011","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cancergen.2015.03.005","article-title":"ARID1A and TERT promoter mutations in dedifferentiated meningioma","volume":"208","year":"2015","journal-title":"Cancer Genet"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0012","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","year":"2014","journal-title":"Brain Pathol"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0013","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0014","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/neuonc\/nov247","article-title":"Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/neuonc\/nov177","article-title":"A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0016","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/neuonc\/nov002","article-title":"Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds","volume":"17","year":"2015","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0017","first-page":"336","article-title":"Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community","volume":"19","year":"2017","journal-title":"Neuro Oncol"},{"issue":"7","key":"key\n\t\t\t\t20171219125453_CIT0018","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/neuonc\/nov303","article-title":"Predicting outcome of epilepsy after meningioma resection","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0019","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/neuonc\/nov285","article-title":"Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/neuonc\/nov183","article-title":"Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"issue":"1","key":"key\n\t\t\t\t20171219125453_CIT0021","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/neuonc\/nou148","article-title":"Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma","volume":"17","year":"2015","journal-title":"Neuro Oncol"},{"issue":"8","key":"key\n\t\t\t\t20171219125453_CIT0022","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/hmg\/2.8.1215","article-title":"Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus","volume":"2","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0023","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/path.4427","article-title":"Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas","volume":"234","year":"2014","journal-title":"J Pathol"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0024","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.2552","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jmg.2010.082420","article-title":"Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas","volume":"48","year":"2011","journal-title":"J Med Genet"},{"issue":"1","key":"key\n\t\t\t\t20171219125453_CIT0026","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10048-009-0204-2","article-title":"Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation","volume":"11","year":"2010","journal-title":"Neurogenetics"},{"issue":"12","key":"key\n\t\t\t\t20171219125453_CIT0027","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","year":"2011","journal-title":"J Med Genet"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0028","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canlet.2015.09.011","article-title":"Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction","volume":"369","year":"2015","journal-title":"Cancer Lett"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0029","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cge.12501","article-title":"A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma","volume":"88","year":"2015","journal-title":"Clin Genet"},{"issue":"8","key":"key\n\t\t\t\t20171219125453_CIT0030","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/neuonc\/nov069","article-title":"Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States","volume":"17","year":"2015","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20171219125453_CIT0031","article-title":"Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010","year":"2016","journal-title":"Neuro Oncol"},{"issue":"12","key":"key\n\t\t\t\t20171219125453_CIT0032","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/00000478-199812000-00005","article-title":"\u201cRhabdoid\u201d meningioma: an aggressive variant","volume":"22","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"key\n\t\t\t\t20171219125453_CIT0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jnen\/nlv006","article-title":"Meningiomas with rhabdoid features lacking other histologic features of malignancy: a study of 44 cases and review of the literature","volume":"75","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0034","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","year":"2016","journal-title":"Nat Genet"},{"issue":"6009","key":"key\n\t\t\t\t20171219125453_CIT0035","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","year":"2010","journal-title":"Science"},{"issue":"10","key":"key\n\t\t\t\t20171219125453_CIT0036","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"key\n\t\t\t\t20171219125453_CIT0037","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2014.10.017","article-title":"Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases","volume":"87","year":"2015","journal-title":"Lung Cancer"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0038","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/0008-5472.CAN-15-0751","article-title":"Gender-specific molecular and clinical features underlie malignant pleural mesothelioma","volume":"76","year":"2016","journal-title":"Cancer Res"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0039","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0000000000000051","article-title":"Recent developments in prognostic and predictive testing in uveal melanoma","volume":"25","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0040","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"key\n\t\t\t\t20171219125453_CIT0041","doi-asserted-by":"crossref","first-page":"e72144","DOI":"10.1371\/journal.pone.0072144","article-title":"A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers","volume":"8","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"key\n\t\t\t\t20171219125453_CIT0042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","year":"2015","journal-title":"Carcinogenesis"},{"issue":"8","key":"key\n\t\t\t\t20171219125453_CIT0043","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jtho.2016.04.028","article-title":"Consensus report of the 2015 Weinman International Conference on Mesothelioma","volume":"11","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"11","key":"key\n\t\t\t\t20171219125453_CIT0044","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","article-title":"Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations","volume":"8","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"1","key":"key\n\t\t\t\t20171219125453_CIT0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","year":"2016","journal-title":"Mod Pathol"},{"issue":"7229","key":"key\n\t\t\t\t20171219125453_CIT0046","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","year":"2009","journal-title":"Nature"},{"issue":"23","key":"key\n\t\t\t\t20171219125453_CIT0047","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"key\n\t\t\t\t20171219125453_CIT0048","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes","volume":"134","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"key\n\t\t\t\t20171219125453_CIT0049","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20171219125453_CIT0050","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","year":"2017","journal-title":"Lancet Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0051","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","article-title":"Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma","volume":"133","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0052","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"7","key":"key\n\t\t\t\t20171219125453_CIT0053","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","year":"2011","journal-title":"Nat Genet"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0054","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/PAS.0000000000000645","article-title":"Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma","volume":"40","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0055","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4161\/epi.24552","article-title":"Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC","volume":"8","year":"2013","journal-title":"Epigenetics"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0056","first-page":"699","article-title":"Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy","volume":"19","year":"2017","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20171219125453_CIT0057","article-title":"Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors","year":"2017","journal-title":"Neuro Oncol"},{"issue":"10","key":"key\n\t\t\t\t20171219125453_CIT0058","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/modpathol.2014.43","article-title":"Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma","volume":"27","year":"2014","journal-title":"Mod Pathol"},{"issue":"12","key":"key\n\t\t\t\t20171219125453_CIT0059","doi-asserted-by":"crossref","first-page":"e1005633","DOI":"10.1371\/journal.pgen.1005633","article-title":"Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s","volume":"11","year":"2015","journal-title":"PLoS Genet"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","article-title":"Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma","volume":"206","year":"2013","journal-title":"Cancer Genet"},{"issue":"32","key":"key\n\t\t\t\t20171219125453_CIT0061","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations","volume":"30","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0062","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20171219125453_CIT0063","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","year":"2012","journal-title":"J Transl Med"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0064","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/13816810.2015.1010734","article-title":"Analysis of BAP1 germline gene mutation in young uveal melanoma patients","volume":"36","year":"2015","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0066","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","article-title":"Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O","volume":"54","year":"2014","journal-title":"Mol Cell"},{"issue":"6101","key":"key\n\t\t\t\t20171219125453_CIT0067","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","year":"2012","journal-title":"Science"},{"issue":"24","key":"key\n\t\t\t\t20171219125453_CIT0068","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1093\/emboj\/cdf691","article-title":"Activation of the E3 ligase function of the BRCA1\/BARD1 complex by polyubiquitin chains","volume":"21","year":"2002","journal-title":"EMBO J"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0069","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","year":"2009","journal-title":"Br J Haematol"},{"issue":"16","key":"key\n\t\t\t\t20171219125453_CIT0070","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","year":"2014","journal-title":"Cancer Res"},{"issue":"9","key":"key\n\t\t\t\t20171219125453_CIT0071","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"Bap1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline Bap1 mutations","volume":"76","year":"2016","journal-title":"Cancer Res"},{"issue":"15","key":"key\n\t\t\t\t20171219125453_CIT0072","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","year":"2016","journal-title":"Oncogene"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0073","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","year":"2012","journal-title":"Cancer Sci"},{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0074","doi-asserted-by":"crossref","first-page":"e0119224","DOI":"10.1371\/journal.pone.0119224","article-title":"BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5\u02b9 splice site in a human mesothelioma cell line","volume":"10","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"key\n\t\t\t\t20171219125453_CIT0075","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/cas.12698","article-title":"Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells","volume":"106","year":"2015","journal-title":"Cancer Sci"},{"issue":"5","key":"key\n\t\t\t\t20171219125453_CIT0076","article-title":"A tumor-specific neo-antigen caused by a frameshift mutation in BAP1 is a potential personalized biomarker in malignant peritoneal mesothelioma","volume":"17","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"key\n\t\t\t\t20171219125453_CIT0077","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma","volume":"18","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"4","key":"key\n\t\t\t\t20171219125453_CIT0078","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1470-2045(15)70056-2","article-title":"Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"16","year":"2015","journal-title":"Lancet Oncol"},{"issue":"23","key":"key\n\t\t\t\t20171219125453_CIT0079","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2014.6096","article-title":"Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial","volume":"311","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nm.4098","article-title":"Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status","volume":"22","year":"2016","journal-title":"Nat Med"},{"issue":"6","key":"key\n\t\t\t\t20171219125453_CIT0081","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nm.4094","article-title":"Reply to \u201cUveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status\u201d","volume":"22","year":"2016","journal-title":"Nat Med"},{"issue":"16","key":"key\n\t\t\t\t20171219125453_CIT0082","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","article-title":"Germline mutations in BAP1 impair its function in DNA double-strand break repair","volume":"74","year":"2014","journal-title":"Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t20171219125453_CIT0083","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","year":"2012","journal-title":"Nat Genet"},{"issue":"3","key":"key\n\t\t\t\t20171219125453_CIT0084","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","year":"2016","journal-title":"Clin Genet"},{"issue":"8","key":"key\n\t\t\t\t20171219125453_CIT0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations","volume":"133","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"key\n\t\t\t\t20171219125453_CIT0086","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.jtho.2016.06.020","article-title":"BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study","volume":"11","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key\n\t\t\t\t20171219125453_CIT0087","article-title":"A population-based analysis of germline BAP1 mutations in melanoma","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"7","key":"key\n\t\t\t\t20171219125453_CIT0088","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"issue":"1","key":"key\n\t\t\t\t20171219125453_CIT0089","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.1014","article-title":"Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma","volume":"44","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"key\n\t\t\t\t20171219125453_CIT0090","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","year":"2013","journal-title":"Nat Genet"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/19\/11\/1447\/22934250\/nox094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T22:13:53Z","timestamp":1719180833000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/19\/11\/1447\/3803447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":90,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,5,8]]},"published-print":{"date-parts":[[2017,10,19]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nox094","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,5,8]]}}}